Skip to main content

Table 5 The Cox proportional hazard model analysis of length of stay using raw cohort and matched cohort

From: Laparoscopic versus open surgery for perihilar cholangiocarcinoma: a multicenter propensity score analysis of short- term outcomes

Risk Factors

Raw Cohort

PSM Matched Cohort

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

HR(95%CI)

P value

HR(95%CI)

P value

HR(95%CI)

P value

HR(95%CI)

P value

Surgery

 LS

Reference

 

Reference

 

Reference

 

Reference

 

 OP

0.67(0.57,0.80)

 < .0001

0.74(0.61,0.90)

0.002

0.66(0.51,0.85)

0.001

0.58(0.45,0.75)

 < .0001

 Female

1.08(0.91,1.27)

0.378

  

0.83(0.64,1.07)

0.147

  

 Age ≥ 60y

1.11(0.94,1.32)

0.228

  

1.10(0.85,1.43)

0.465

  

BMI

 18.5

Reference

   

Reference

   

 18.5 ~ 24

1.39(0.93,2.06)

0.108

  

0.84(0.44,1.59)

0.584

  

 > 24

1.07(0.89,1.29)

0.480

  

1.14(0.86,1.52)

0.360

  

ASA

 I

Reference

   

Reference

   

 II

0.91(0.74,1.11)

0.347

  

0.91(0.68,1.20)

0.494

  

 III

0.81(0.62,1.06)

0.131

  

0.73(0.49,1.09)

0.120

  

CA199, U/ml

  ≤ 50

Reference

 

Reference

 

Reference

 

Reference

 

 50 ~ 400

0.57(0.46,0.72)

 < .0001

0.60(0.47,0.76)

 < .0001

0.67(0.48,0.95)

0.025

0.455(0.315,0.658)

 < .0001

  ≥ 400

0.64(0.50,0.81)

0.001

0.59(0.450,0.77)

 < .0001

0.75(0.50,1.11)

0.144

0.424(0.279,0.645)

 < .0001

 Tumor size > 3 cm

1.12(0.94,1.33)

0.214

  

1.01(0.76,1.33)

0.963

  

 Lymphnodes > 8

0.91(0.75,1.09)

0.292

  

1.03(0.78,1.36)

0.855

  

 Preoperative Tbil > 85.5 μmol/L

0.85(0.73,1.01)

0.057

  

0.77(0.58,1.02)

0.064

  

 Preoperative AST > 40 μmol/L

0.69(0.58,0.83)

 < .0001

  

0.83(0.62,1.11)

0.208

  

 Preoperative ALT > 40 μmol/L

0.59(0.48,0.71)

 < .0001

0.74(0.59,0.91)

0.005

0.62(0.46,0.84)

0.002

  

CA199, U/ml

  ≤ 50

Reference

 

Reference

 

Reference

 

Reference

 

 50 ~ 400

0.57(0.46,0.72)

 < .0001

0.60(0.47,0.76)

 < .0001

0.67(0.48,0.95)

0.025

0.46(0.32,0.66)

 < .0001

  ≥ 400

0.64(0.50,0.81)

 < .0001

0.59(0.45,0.77)

 < .0001

0.75(0.50,1.11)

0.144

0.42(0.28,0.65)

 < .0001

Operating time, min

 ≤ 200

Reference

   

Reference

   

 200 ~ 400

1.13(0.84,1.51)

0.428

  

1.23(0.79,1.91)

0.353

  

  ≥ 400

0.94(0.68,1.29)

0.683

  

1.20(0.75,1.93)

0.446

  

IBL, ml

  ≤ 100

Reference

   

Reference

   

 100 ~ 500

0.75(0.62,0.92)

0.004

0.95(0.77,1.17)

0.625

0.90(0.66,1.23)

0.523

  

  ≥ 500

0.49(0.39,0.61)

 < .0001

0.54(0.42,0.69)

 < .0001

0.66(0.47,0.91)

0.013

  

Transfusion during surgery

Hepatectomy

 Bile duct only

Reference

   

Reference

   

 Left hemihepatectomy

1.16(0.97,1.39)

0.100

1.26(1.02,1.55)

0.029

1.02(0.77,1.35)

0.909

  

 Right hemihepatectomy

0.57(0.43,0.75)

 < .0001

0.78(0.57,1.05)

0.104

0.72(0.49,1.07)

0.102

  

 Left Segmentectomy

0.73(0.32,1.64)

0.444

1.06(0.45,2.47)

0.895

0.81(0.25,2.55)

0.712

  

 Right Segmentectomy

0.73(0.34,1.54)

0.403

0.88(0.38,2.02)

0.761

0.64(0.26,1.58)

0.336

  

 Bile duct and part of hepatectomy

0.67(0.41,1.08)

0.098

0.78(0.45,1.37)

0.390

0.86(0.47,1.56)

0.618

  

 Conversion to laparotomy

0.80(0.50,1.28)

0.351

  

0.79(0.43,1.44)

0.440

  

Vascular resection

 None

Reference

   

Reference

   

 Hepatic artery

0.74(0.52,1.06)

0.101

  

0.79(0.48,1.29)

0.342

  

 Portal vein

0.71(0.46,1.10)

0.127

  

0.54(0.24,1.22)

0.138

  

 Hepatic artery & Portal vein

0.44(0.32,0.61)

 < .0001

  

0.49(0.29,0.81)

0.006

  

 Vascular reconstruction

0.74(0.50,1.11)

0.141

  

0.58(0.30,1.12)

0.105

  

Digestive reconstruction

 Choledochojejunostomy

Reference

   

Reference

   

 Hepaticojejunostomy

0.69(0.58,0.82)

 < .0001

0.808(0.662,0.986)

0.035

0.75(0.58,0.98)

0.034

  

 Biliary plasty

0.93(0.79,1.10)

0.377

  

1.02(0.80,1.308)

0.868

  

TNM

 I(T1N0M0)

Reference

 

Reference

 

Reference

   

 II(T2a/2bN0M0)

0.94(0.73,1.21)

0.636

1.04(0.80,1.36)

0.777

0.97(0.67,1.39)

0.851

  

 IIIA(T3N0M0)

0.82(0.59,1.14)

0.238

0.95(0.66,1.36)

0.761

0.88(0.511,1.53)

0.655

  

 IIIB(T4N0M0)

1.43(1.01,2.03)

0.047

2.40(1.62,3.55)

 < .0001

1.29(0.72,2.31)

0.388

  

 IVA(T, N2M0)

0.80(0.60,1.06)

0.119

1.13(0.83,1.54)

0.444

0.82(0.53,1.24)

0.343

  

 IVB(T,N,M1)

0.95(0.65,1.38)

0.788

1.09(0.74,1.62)

0.665

0.83(0.47,1.48)

0.534

  

 Abdominal abscess

0.44(0.33,0.59)

 < .0001

0.46(0.34,0.62)

 < .0001

0.47(0.31,0.70)

0.0002

0.41(0.27,0.63)

 < .0001

 Hemorrhage

0.44(0.29,0.67)

 < .0001

0.39(0.26,0.61)

 < .0001

0.50(0.28,0.92)

0.027

0.33(0.18,0.63)

0.0007

 Biliary fistula

0.49(0.35,0.68)

 < .0001

0.50(0.36,0.71)

 < .0001

0.64(0.39,1.04)

0.074

0.54(0.33,0.89)

0.016

 Heart failure

0.46(0.25,0.86)

0.016

0.26(0.13,0.51)

 < .0001

0.39(0.14,1.05)

0.061

0.18(0.07,0.50)

0.001

 Incision infection

0.31(0.17,0.54)

 < .0001

0.37(0.21,0.66)

0.001

0.39(0.19,0.80)

0.009

  

 Pneumonia

0.49(0.35,0.69)

 < .0001

0.49(0.34,0.71)

 < .0001

0.67(0.41,1.09)

0.105

  

 ARDS

0.36(0.17,0.75)

0.007

  

0.45(0.17,1.20)

0.109

  

 Liver failure

0.37(0.18,0.79)

0.010

  

0.38(0.12,1.17)

0.092

  

 Reoperation

0.25(0.10,0.61)

0.002

  

0.21(0.07,0.65)

0.007

0.308(0.10,0.98)

0.046

 Renal failure

0.28(0.12,0.69)

0.005

  

0.29(0.09,0.90)

0.032

  
  1. PSM Propensity score matching, LS Laparoscopic surgery, OP Open operation, HR Hazard ratio, BMI Body mass index, ALP A Lkaline Phosphatase, AST Aspartic acid aminotransferase, ALT alanine aminotransferase, IBL Intraoperative blood loss, ARDS Acute Respiratory Distress Syndrome